Ronald W. Pero
Chief Tech/Sci/R&D Officer bij RezGen5 Ltd.
Profiel
Ronald W.
Pero is a Professor-Emeritus at the University of Lund.
He is also the Chief Scientific Officer at RezGen5 Ltd.
and a Founding Member of Campamed, Inc. and Deep South Partners LLC.
Previously, he was a Founding Member of Oncotelic Therapeutics, Inc. and Optigenex, Inc.
Actieve functies van Ronald W. Pero
| Bedrijven | Functie | Begin |
|---|---|---|
RezGen5 Ltd.
 RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Chief Tech/Sci/R&D Officer | - |
| University of Lund | Corporate Officer/Principal | - |
| Campamed, Inc. | Corporate Officer/Principal | - |
| Deep South Partners LLC | Corporate Officer/Principal | - |
Eerdere bekende functies van Ronald W. Pero
| Bedrijven | Functie | Einde |
|---|---|---|
| OPTIGENEX INC. | Corporate Officer/Principal | - |
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| OPTIGENEX INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
RezGen5 Ltd.
RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Health Technology |
| Campamed, Inc. | |
| Deep South Partners LLC |
